| 000 | 01807cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030453.0 | ||
| 008 | 110925s2011 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.15.M.Sc.2011.Ho.O | ||
| 100 | 0 | _aHossam Eldin Mohammed Mahgoub | |
| 245 | 1 | 0 |
_aOral versus vaginal misoprostol in the management of blighted ovum / _cHossam Eldin Mohammed Mahgoub ; Supervised Medhat Mosad Mosaad Eltammamy , Ahmed Mahmoud Sayed Aly , Abdelgany Mohamed Abdelgany |
| 246 | 1 | 5 | _aمقارنة بين استخدام عقار الميزبروستول عن طريق الفم واستخدامة عن طريق المهبل فى علاج حمل الحويصلة الفارغة |
| 260 |
_aCairo : _bHossam Eldin Mohammed Mahgoub , _c2011 |
||
| 300 |
_a151 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Gynecology and Obstetrics | ||
| 520 | _aTo compare the efficacy , side effects and patient satisfaction between oral 400 microgram misoprostol and vaginal 400 microgram misoprostal in management of blighted ovum . 60 women diagnosed as have blighted ovum divided into two groups each group contain 30 women . group (A) received 400 microgram misoprostol vaginally . group (B) received 400 microgram orally | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBlighted ovum | |
| 653 | 4 | _aMisoprostol | |
| 653 | 4 | _aOrally | |
| 700 | 0 |
_aAbdelgany Mohamed Abdelgany , _eSupervisor |
|
| 700 | 0 |
_aAhmed Mahmoud Sayed Aly , _eSupervisor |
|
| 700 | 0 |
_aMedhat Mosad Mosaad Eltammamy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c35388 _d35388 |
||